Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 6,361,323 | 6,219,323 | -142,000 | $1.19B | $1.28B | 25.38% | +$85.23M |
| Genmab A/SADS(GMAB) | 13,133,131 | 14,136,472 | +1,003,341 | $360.77M | $504.32M | 10.03% | +$143.55M |
| Edgewise Therapeutics, Inc.(EWTX) | 10,215,455 | 10,778,665 | +563,210 | $415.05M | $437.61M | 8.70% | +$22.56M |
| Spyre Therapeutics, Inc.(SYRE) | 3,840,778 | 4,457,450 | +616,672 | $340.98M | $396.85M | 7.89% | +$55.86M |
| Insmed Incorporated(INSM) | 1,325,977 | 2,695,977 | +1,370,000 | $141.38M | $307.72M | 6.12% | +$166.34M |
| MBX Biosciences, Inc.(MBX) | 2,508,015 | 3,772,885 | +1,264,870 | $138.44M | $221.17M | 4.40% | +$82.72M |
| Oruka Therapeutics, Inc.(ORKA) | 2,144,526 | 2,493,507 | +348,981 | $204.09M | $207.68M | 4.13% | +$3.59M |
| Belite Bio, IncADS(BLTE) | 1,232,877 | 1,142,123 | -90,754 | $189.84M | $193.96M | 3.86% | +$4.11M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,775,649 | 2,301,375 | -474,274 | $174.70M | $180.91M | 3.60% | +$6.21M |
| Tango Therapeutics, Inc.(TNGX) | 6,357,523 | 6,961,546 | +604,023 | $198.74M | $173.69M | 3.45% | -$25.05M |
| Viridian Therapeutics, Inc.(VRDN) | 6,723,788 | 8,257,672 | +1,533,884 | $123.52M | $170.03M | 3.38% | +$46.51M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 2,347,850 | +2,347,850 | $0 | $154.49M | 3.07% | +$154.49M |
| Vaxcyte, Inc.(PCVX) | 2,127,852 | 2,142,852 | +15,000 | $123.69M | $121.93M | 2.42% | -$1.76M |
| Erasca, Inc.(ERAS) | 9,550,000 | 7,998,257 | -1,551,743 | $174.96M | $117.25M | 2.33% | -$57.70M |
| Jade Biosciences Inc | 2,857,405 | 6,053,268 | +3,195,863 | $63.49M | $85.05M | 1.69% | +$21.56M |
| Tyra Biosciences, Inc.(TYRA) | 1,828,607 | 3,510,360 | +1,681,753 | $58.41M | $76.77M | 1.53% | +$18.37M |
| Olema Pharmaceuticals Inc | 8,670,576 | 8,720,576 | +50,000 | $108.47M | $75.35M | 1.50% | -$33.12M |
| Obsidian Therapeutics Inc | 0 | 4,155,214 | +4,155,214 | $0 | $57.05M | 1.13% | +$57.05M |
| Structure Therapeutics IncADS | 0 | 1,299,199 | +1,299,199 | $0 | $40.63M | 0.81% | +$40.63M |
| Achieve Life Science Inc | 4,951,856 | 4,951,856 | 0 | $32.34M | $40.06M | 0.80% | +$7.72M |
| Veradermics, Incorporated(MANE) | 0 | 310,060 | +310,060 | $0 | $37.59M | 0.75% | +$37.59M |
| Assembly Biosciences Inc | 1,553,748 | 1,553,748 | 0 | $42.70M | $36.50M | 0.73% | -$6.20M |
| Oric Pharmaceuticals Inc | 0 | 1,505,769 | +1,505,769 | $0 | $20.28M | 0.40% | +$20.28M |
| Korsana Biosciences Inc | 0 | 613,914 | +613,914 | $0 | $19.65M | 0.39% | +$19.65M |
| Editas Medicine Inc | 5,586,625 | 7,575,140 | +1,988,515 | $18.10M | $19.47M | 0.39% | +$1.37M |
| Hemab Therapeutics Hldgs Inc | 0 | 629,347 | +629,347 | $0 | $19.41M | 0.39% | +$19.41M |
| Vor Biopharma Inc.(VOR) | 1,750,000 | 889,575 | -860,425 | $32.22M | $16.97M | 0.34% | -$15.24M |
| Kardigan Inc | 900,000 | 900,000 | 0 | $21.46M | $13.28M | 0.26% | -$8.19M |
| Tcgx Acquisition CorpCL A | 0 | 300,000 | +300,000 | $0 | $3.75M | 0.07% | +$3.75M |
| Inventiva SaADS | 4,000,000 | 808,176 | -3,191,824 | $15.12M | $2.98M | 0.06% | -$12.14M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 480,000 | 0 | -480,000 | $144.49M | $0 | — | -$144.49M |
| Apogee Therapeutics Inc | 1,576,385 | 0 | -1,576,385 | $209.23M | $0 | — | -$209.23M |
| EyePoint, Inc.(EYPT) | 2,890,397 | 0 | -2,890,397 | $41.33M | $0 | — | -$41.33M |
| Lexeo Therapeutics, Inc.(LXEO) | 4,175,382 | 0 | -4,175,382 | $19.44M | $0 | — | -$19.44M |
| MapLight Therapeutics, Inc.(MPLT) | 685,852 | 0 | -685,852 | $24.58M | $0 | — | -$24.58M |
| Nuvalent Inc | 5,924,433 | 0 | -5,924,433 | $731.67M | $0 | — | -$731.67M |